Divi's Laboratories Limited (NSE:DIVISLAB)
India
· Delayed Price · Currency is INR 5,687.00
-2.50 (-0.04%)
Sep 29, 2025, 9:42 AM IST
Revenue by Product
Fiscal year is April - March.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2005 - 2019 |
| Active Pharmaceutical Ingredients and Intermediates | 93.60B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Active Pharmaceutical Ingredients and Intermediates Growth | 19.31% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is April - March.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2005 - 2019 |
| Europe | 33.57B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe Growth | 10.57% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Switzerland | 19.08B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Switzerland Growth | 86.15% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States | 13.06B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | 24.74% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| India | 11.07B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| India Growth | 12.50% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia | 10.44B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia Growth | 2.65% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of the World | 3.67B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of the World Growth | 4.56% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Americas | 2.71B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Americas Growth | -29.61% |
Log In |
Log In |
Log In |
Log In | Upgrade
|